280 related articles for article (PubMed ID: 11264342)
1. Antiviral effect of N-butyldeoxynojirimycin against bovine viral diarrhea virus correlates with misfolding of E2 envelope proteins and impairment of their association into E1-E2 heterodimers.
Branza-Nichita N; Durantel D; Carrouée-Durantel S; Dwek RA; Zitzmann N
J Virol; 2001 Apr; 75(8):3527-36. PubMed ID: 11264342
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of host ER glucosidase activity prevents Golgi processing of virion-associated bovine viral diarrhea virus E2 glycoproteins and reduces infectivity of secreted virions.
Jordan R; Nikolaeva OV; Wang L; Conyers B; Mehta A; Dwek RA; Block TM
Virology; 2002 Mar; 295(1):10-9. PubMed ID: 12033761
[TBL] [Abstract][Full Text] [Related]
3. Novel imino sugar α-glucosidase inhibitors as antiviral compounds.
Howe JD; Smith N; Lee MJ; Ardes-Guisot N; Vauzeilles B; Désiré J; Baron A; Blériot Y; Sollogoub M; Alonzi DS; Butters TD
Bioorg Med Chem; 2013 Aug; 21(16):4831-8. PubMed ID: 23582447
[TBL] [Abstract][Full Text] [Related]
4. [Affect of deoxynojirimycin derivatives on hepatitis C virus morphogenesis].
Timokhova AV; Bakinovskiĭ LV; Zinin AI; Popenko VI; Ivanov AV; Rubtsov PM; Kochetkov SN; Belzhelarskaia SN
Mol Biol (Mosk); 2012; 46(4):644-53. PubMed ID: 23113354
[TBL] [Abstract][Full Text] [Related]
5. The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy.
Ouzounov S; Mehta A; Dwek RA; Block TM; Jordan R
Antiviral Res; 2002 Sep; 55(3):425-35. PubMed ID: 12206880
[TBL] [Abstract][Full Text] [Related]
6. Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins.
Choukhi A; Ung S; Wychowski C; Dubuisson J
J Virol; 1998 May; 72(5):3851-8. PubMed ID: 9557669
[TBL] [Abstract][Full Text] [Related]
7. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents.
Zitzmann N; Mehta AS; Carrouée S; Butters TD; Platt FM; McCauley J; Blumberg BS; Dwek RA; Block TM
Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11878-82. PubMed ID: 10518544
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin.
Dubuisson J; Rice CM
J Virol; 1996 Feb; 70(2):778-86. PubMed ID: 8551615
[TBL] [Abstract][Full Text] [Related]
9. Rubella virus glycoprotein interaction with the endoplasmic reticulum calreticulin and calnexin.
Nakhasi HL; Ramanujam M; Atreya CD; Hobman TC; Lee N; Esmaili A; Duncan RC
Arch Virol; 2001; 146(1):1-14. PubMed ID: 11266204
[TBL] [Abstract][Full Text] [Related]
10. Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus.
Durantel D; Branza-Nichita N; Carrouée-Durantel S; Butters TD; Dwek RA; Zitzmann N
J Virol; 2001 Oct; 75(19):8987-98. PubMed ID: 11533162
[TBL] [Abstract][Full Text] [Related]
11. Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells.
Brazzoli M; Helenius A; Foung SK; Houghton M; Abrignani S; Merola M
Virology; 2005 Feb; 332(1):438-53. PubMed ID: 15661174
[TBL] [Abstract][Full Text] [Related]
12. Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors.
Chapel C; Garcia C; Bartosch B; Roingeard P; Zitzmann N; Cosset FL; Dubuisson J; Dwek RA; Trépo C; Zoulim F; Durantel D
J Gen Virol; 2007 Apr; 88(Pt 4):1133-1143. PubMed ID: 17374756
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus glycoprotein E2 binding to CD81: the role of E1E2 cleavage and protein glycosylation in bioactivity.
Chan-Fook C; Jiang WR; Clarke BE; Zitzmann N; Maidens C; McKeating JA; Jones IM
Virology; 2000 Jul; 273(1):60-6. PubMed ID: 10891408
[TBL] [Abstract][Full Text] [Related]
14. Formation of bovine viral diarrhea virus E1-E2 heterodimers is essential for virus entry and depends on charged residues in the transmembrane domains.
Ronecker S; Zimmer G; Herrler G; Greiser-Wilke I; Grummer B
J Gen Virol; 2008 Sep; 89(Pt 9):2114-2121. PubMed ID: 18753220
[TBL] [Abstract][Full Text] [Related]
15. Role of disulfide bond formation in the folding and assembly of the envelope glycoproteins of a pestivirus.
Branza-Nichita N; Lazar C; Durantel D; Dwek RA; Zitzmann N
Biochem Biophys Res Commun; 2002 Aug; 296(2):470-6. PubMed ID: 12163043
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
Lazar C; Durantel D; Macovei A; Zitzmann N; Zoulim F; Dwek RA; Branza-Nichita N
Antiviral Res; 2007 Oct; 76(1):30-7. PubMed ID: 17548120
[TBL] [Abstract][Full Text] [Related]
17. Natural iminosugar derivatives of 1-deoxynojirimycin inhibit glycosylation of hepatitis viral envelope proteins.
Jacob JR; Mansfield K; You JE; Tennant BC; Kim YH
J Microbiol; 2007 Oct; 45(5):431-40. PubMed ID: 17978803
[TBL] [Abstract][Full Text] [Related]
18. Folding and maturation of tyrosinase-related protein-1 are regulated by the post-translational formation of disulfide bonds and by N-glycan processing.
Negroiu G; Dwek RA; Petrescu SM
J Biol Chem; 2000 Oct; 275(41):32200-7. PubMed ID: 10915799
[TBL] [Abstract][Full Text] [Related]
19. [The role of chaperone proteins in the assembly of envelope proteins of hepatitis C virus].
Dubuisson J
Bull Mem Acad R Med Belg; 1998; 153(7-9):343-9; discussion 350-1. PubMed ID: 10100398
[TBL] [Abstract][Full Text] [Related]
20. Role of N-glycan trimming in the folding and secretion of the pestivirus protein E(rns).
Branza-Nichita N; Lazar C; Dwek RA; Zitzmann N
Biochem Biophys Res Commun; 2004 Jun; 319(2):655-62. PubMed ID: 15178456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
